BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/29/2014 5:07:00 PM | Browse: 833 | Download: 703
Publication Name World Journal of Gastroenterology
Manuscript ID 6269
Country Nigeria
Received
2013-10-11 16:44
Peer-Review Started
2013-10-12 15:16
To Make the First Decision
2013-11-21 20:53
Return for Revision
2013-11-22 16:34
Revised
Second Decision
2014-01-05 14:56
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2014-01-05 15:19
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2014-03-11 19:03
Publish the Manuscript Online
2014-04-04 15:11
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Autobiography
Article Title Rabeprazole, clarithromycin, and amoxicillin Helicobacter pylori eradication therapy: Report of an efficacy study
Manuscript Source Invited Manuscript
All Author List Charles Asabamaka Onyekwere, Joan Nwabuaku Odiagah, Rufina Igetei, Amancia Olufunmilayo Duro Emanuel, Francis Ekere and Stella Smith
Funding Agency and Grant Number
Corresponding Author Dr. Charles Asabamaka Onyekwere, Department of Medicine, Lagos State University Teaching Hospital, Mobolaji Bank Anthony Way, Ikeja, lagos 999062, Nigeria. ifymobi@yahoo.com
Key Words Helicobacter pylori; Eradication therapy; Amoxicillin clarithromycin; Rabeprazole triple therapy
Core Tip Helicobacter pylori (H. pylori) infection is widespread in Nigeria, along with the associated risk of serious gastroduodenal diseases, including gastric cancer. The use of different eradication therapies for H. pylori is commonplace, as no consensus exists regarding the optimal treatment regimen, despite guidelines and recommendations. This lack of consensus is most likely due to the lack of evidence-based data, and the findings in this report may help to fill this gap.
Publish Date 2014-04-04 15:11
Citation Onyekwere CA, Odiagah JN, Igetei R, Duro Emanuel AO, Ekere F, Smith S. Rabeprazole, clarithromycin, and amoxicillin Helicobacter pylori eradication therapy: Report of an efficacy study. World J Gastroenterol 2014; 20(13): 3615-3619
URL http://www.wjgnet.com/1007-9327/full/v20/i13/3615.htm
DOI http://dx.doi.org/10.3748/wjg.v20.i13.3615
Full Article (PDF) WJG-20-3615.pdf
Full Article (Word) WJG-20-3615.doc
Manuscript File 6269-Review.docx
Answering Reviewers 6269-Answering reviewers.pdf
Copyright License Agreement 6269-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate 6269-Language certificate.pdf
Peer-review Report 6269-Peer review(s).pdf
Scientific Editor Work List 6269-Scientific editor work list.doc